18 Jul RiverVest Venture Partners Promotes Andrew Kleiboeker and Jeff Seitz

Posted at 14:51h in RiverVest News by kelly 0 Comments

JULY 2024RiverVest Venture Partners Announces Promotions /*! elementor - v3.22.0 - 26-06-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (July 18, 2024)ST. LOUIS, July 18, 2024– RiverVest Venture Partners today announced the promotions of two members of its team.  Andrew Kleiboeker has been promoted to associate, and...

Read More

10 Jun IN THE NEWS / RiverVest’s Niall O’Donnell, Ph.D. Honored by UC San Diego’s Rady School of Management’s Sullivan Center for Entrepreneurship

Posted at 16:46h in RiverVest News by kelly 0 Comments

June 2024O'Donnell Honored for Entrepreneurial Achievement by UC San Diego's Rady School of Management /*! elementor - v3.21.0 - 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Niall O'Donnell, Ph.D. RiverVest Managing Director San Diego, CA (June 5, 2024) – UC San Diego’s Rady School of Management named Niall O’Donnell,...

Read More

26 Feb EXPERT INSIGHT: Global Clinical Trial Investigates Novel Heart Failure Treatment

Posted at 15:15h in Expert Insights by kelly 0 Comments

RiverVest's latest Expert Insight explores the role of patient advocacy groups in therapeutic drug development for patients with rare diseases such as mitochondrial disease. ...

Read More

13 Dec RiverVest Venture Partners Promotes Karen Spilizewski and Isaac Zike to Managing Director and Pascal Krotee to Principal

Posted at 18:38h in RiverVest News by kelly 0 Comments

DECEMBER 2023RiverVest Venture Partners Promotes Karen Spilizewski and Isaac Zike to Managing Director and Pascal Krotee to Principal /*! elementor - v3.22.0 - 26-06-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (December 14, 2023)ST. LOUIS, December 14, 2023 – RiverVest Venture Partners today announced the promotions of...

Read More

03 Nov IN THE NEWS / RiverVest’s Pascal Krotee Wins Life Science Catalyst Award

Posted at 12:44h in RiverVest News by kelly 0 Comments

November 2023RiverVest's Pascal Krotee Wins Life Science Catalyst Award /*! elementor - v3.17.0 - 01-11-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Pascal Krotee, Ph.D. RiverVest Senior Associate San Diego, CA (November 1, 2023) – Biocom California today announced the winners of its Eighth Annual Life Science Catalyst Award. RiverVest...

Read More

08 Aug EXPERT INSIGHT: Mitochondrial Challenges: Innovations in Research and Patient-Centered Care

Posted at 19:18h in Expert Insights by kelly 0 Comments

RiverVest's latest Expert Insight explores the role of patient advocacy groups in therapeutic drug development for patients with rare diseases such as mitochondrial disease. ...

Read More

03 Aug CASE STUDY: GOOD THERAPEUTICS

Posted at 16:26h in Case Study by kelly 0 Comments

This is a case study of RiverVest portfolio company Good Therapeutics, which was acquired by Roche in 2022 for $250 million upfront plus potential milestone returns....

Read More

13 Jun EXPERT INSIGHT / The Orphan Drug Act of 1983 by Niall O’Donnell, Ph.D.

Posted at 18:23h in Expert Insights by kelly 0 Comments

In this article, Managing Director Niall O’Donnell, Ph.D. discusses the law that transformed orphan drug development and how one actor’s starring role in its passage spurred 40 years of prolific, life-saving innovation. ...

Read More

24 Apr CASE STUDY: Standard Bariatrics

Posted at 19:39h in Case Study by kelly 0 Comments

This is a case study of RiverVest's role in financing and guiding Cincinnati-based portfolio company Standard Bariatrics through acquisition by Teleflex, Inc....

Read More

03 Jan IN THE NEWS / RiverVest’s Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020

Posted at 00:00h in RiverVest News by kelly 0 Comments

JAN 2020RiverVest's Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020 /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (January 3, 2020) St. Louis Business JournalRead the Press ReleasePerhaps no part of the St. Louis economy surged in the past decade more...

Read More